Clive Meanwell - 24 Aug 2021 Form 4 Insider Report for Population Health Investment Co., Inc.

Reporting relationship: Chief Executive Officer, Director
Issuer ticker: N/A
Reported as of: 24 Aug 2021
Net transaction value: +$176,469
SEC form: 4
Accepted by SEC: 25 Aug 2021, 21:21:15 UTC
Next SEC filing: 20 Dec 2021
Source filing: View source filing
Reporting owner signature: /s/ Christopher Visioli, Attorney-in-Fact

Key filing fact

Clive Meanwell filed Form 4 for Population Health Investment Co., Inc. on 25 Aug 2021.

Key facts

This page summarizes Clive Meanwell's Form 4 filing for Population Health Investment Co., Inc..
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 25 Aug 2021, 21:21.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: +$176,469.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PHIC transaction

Class A Ordinary Shares

Purchase

Transaction value: $49,929
Shares: +5,100
Change %: +45%
Price: $9.79
Shares after: 16,400
Date: 24 Aug 2021
Ownership: Direct

PHIC transaction

Class A Ordinary Shares

Purchase

Transaction value: $110,740
Shares: +11,300
Change %
Price: $9.80
Shares after: 11,300
Date: 24 Aug 2021
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

PHIC transaction Derivative

Warrants to purchase Class A Ordinary Share

Purchase

Transaction value: $15,800
Shares: +20,000
Change %
Price: $0.7900^*
Shares after: 20,000
Date: 24 Aug 2021
Ownership: Direct
Underlying class: Class A Ordinary Shares
Underlying amount: 20,000
Exercise price: $11.50
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The warrants become exercisable on the later of (i) 30 days after the completion of the registrant's initial business combination and (ii) 12 months from the closing of the registrant's initial public offering.

Footnote F2

The warrants expire 5 years after the completion of the registrant's initial business combination or earlier upon redemption or liquidation, as described in the registrant's prospectus filed with the SEC.